Oncolytic Biotechnology

Oncolytic Biotechnology is the study of oncolytic virus, the virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumour. Oncolytic viruses are thought not only to cause direct destruction of the tumour cells, but also to stimulate host anti-tumour immune responses.

    Related Conference of Oncolytic Biotechnology

    December 11-12, 2025

    7th International Conference on Biochemistry

    Prague, Czech Republic
    December 22-23, 2025

    29th World Congress on Biotechnology

    Barcelona, Spain
    February 25-26, 2026

    6th International Conference on Biomedicine & Pharmacotherapy

    Rome, Italy
    March 23-24, 2026

    29th European Biotechnology Congress

    Rome, Italy
    April 27-28, 2026

    7th Annual Congress on Biosimilars and Future Biotherapeutics

    Paris, France
    April 27-28, 2026

    32nd Asia Pacific Biotechnology Congress

    Dubai, UAE
    June 29-30, 2026

    41st International Conference on Next-Gen Biotechnology and Applications

    Aix-en-Provence, France
    July 23-24, 2026

    27th Global Summit on Analytical and Bioanalytical Techniques

    Paris, France
    August 27-28, 2026

    30th Global Congress on Biotechnology

    Berlin, Germany

    Oncolytic Biotechnology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in